Exact Mass: 697.2863127999999

C34H51NO14 (697.3309386000001)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AB - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives Same as: D02549

Bz-Ile-glu-gly-arg-pna

4-{[({4-carbamimidamido-1-[(4-nitrophenyl)carbamoyl]butyl}-C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-4-[(1-hydroxy-2-{[hydroxy(phenyl)methylidene]amino}-3-methylpentylidene)amino]butanoate

C32H43N9O9 (697.3183588)

1alpha,2alpha-diacetoxy-8beta-isobutanoyloxy-9alpha-benzoyloxy-13-nicotinoyloxy-4beta,6beta-dihydroxy-beta-dihydroagarofuran

C36H43NO13 (697.2734268)

tetrin B

2-O-trans-sinapoyldemethylalangiside

Damavaricin D

longphyllineside A

1beta-acetoxy-2beta-isobutyryloxy-4alpha-hydroxy-6alpha-hydroxy-8alpha-nicotinoyloxy-9beta-benzoyloxy-11-acetoxy-dihydro-beta-agarofuran

C36H43NO13 (697.2734268)

6-O-trans-Sinapoyl-demethylalangiside

C31H59NO7Si5 (697.3137704000001)

6-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether

His Glu Glu Arg Gln

C27H43N11O11 (697.3143368)

Phe Glu Glu Phe Leu

C35H47N5O10 (697.3322762)

HEERQ

His-Glu-Glu-Arg-Gln

C27H43N11O11 (697.3143368)

TRIS(2 6-DIISOPROPYLPHENOXY)NIOBIUM(V)

C36H54Cl2NbO3 (697.2513574)

(1R,2R)-N,N-BIS[3-OXO-2-(2,4,6-TRIMETHYLBENZOYL)BUTYLIDENE]-1,2-DIPHENYLETHYLENEDIAMINATO COBALT(II)

C42H42CoN2O4 (697.2476392)

(1S,2S)-N,N-Bis[3-oxo-2-(2,4,6-trimethylbenzoyl)butylidene]-1,2-diphenylethylenediaminato Cobalt(II)

C42H42CoN2O4 (697.2476392)

Betalutin

C30H47N7O10S (697.3104962)

D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies

25-acetylchaxamycin C

N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

C33H48NO13P (697.2863127999999)

PS 20:4/8:3;O2

C34H52NO12P (697.3226962)

PS 20:5/7:3;O3

PS 20:5/8:2;O2

C34H52NO12P (697.3226962)

PS 27:8;O3

C33H48NO13P (697.2863127999999)

PS 28:7;O2

C34H52NO12P (697.3226962)

QWF Peptide

C38H43N5O8 (697.3111478000001)

QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1]. QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1].

(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r,15r)-2,4,7,14,15-pentakis(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-8-yl pyridine-3-carboxylate

C36H43NO13 (697.2734268)

[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2z)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2z)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate